CVE-2018-15371

Cisco IOS XE Software Shell Access Authentication Bypass Vulnerability

Description

A vulnerability in the shell access request mechanism of Cisco IOS XE Software could allow an authenticated, local attacker to bypass authentication and gain unrestricted access to the root shell of an affected device. The vulnerability exists because the affected software has insufficient authentication mechanisms for certain commands. An attacker could exploit this vulnerability by requesting access to the root shell of an affected device, after the shell access feature has been enabled. A successful exploit could allow the attacker to bypass authentication and gain unrestricted access to the root shell of the affected device.

Categories

6.7
CVSS
Severity: Medium
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.05%
Vendor Advisory cisco.com
Affected: Cisco Cisco IOS XE Software
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2018-15371?
CVE-2018-15371 has been scored as a medium severity vulnerability.
How to fix CVE-2018-15371?
To fix CVE-2018-15371, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2018-15371 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2018-15371 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2018-15371?
CVE-2018-15371 affects Cisco Cisco IOS XE Software.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.